Drug intelligence / Profile preview

NagPet

Development stage
Unknown
Lead developer
Bionag
Modality
Nanoparticles → Drug Delivery Systems
Administration
Oral, Topical, Intravenous, Intramuscular, Subcutaneous, Ophthalmic, Otic
01

Overview

NagPet is a veterinary antimicrobial suspension developed by Bionag, utilizing silver nanoparticles (AgNPs) as the active therapeutic agent. It is designed for the treatment of a broad spectrum of systemic and localized infections in companion animals, including dogs and cats. The silver nanoparticles exert their effect through multiple mechanisms: they release silver ions that disrupt microbial cell membranes, generate reactive oxygen species (ROS) leading to oxidative stress, and bind to microbial DNA and proteins to inhibit replication and metabolic functions. NagPet is indicated for severe viral conditions such as Canine Parvovirus and Feline Panleukopenia, as well as systemic bacterial and fungal infections, respiratory complexes, and various dermatological conditions and wounds.

Brand names
NagPet
Other names
Bionag silver nanoparticlesNagPet-Bionag
02

Targets

Neuraminidase

Beyond the preview

Go deeper on NagPet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NagPet.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call